Role of NAD(P)H:quinone oxidoreductase polymorphism at codon 187 in susceptibility to lung, laryngeal and oral/pharyngeal cancers

Biomarkers

Volumn 6, Issue 6, 2001, Pages 440-447

  Benhamou, S ^a   Voho, A ^a   Bouchardy, C ^a   Mitrunen, K ^a   Dayer, P ^a   Hirvonen, A ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Epidemiology; Laryngeal cancer; Lung cancer; NQO1 genotype; Oral cavity pharyngeal cancer; Tobacco smoking

Indexed keywords

AMINO ACID; BENZO[A]PYRENE; CYTOSINE; OXIDOREDUCTASE; PROLINE; PROTEIN; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SERINE; THYMINE;

ADULT; AGED; ALLELE; AMINO ACID COMPOSITION; ARTICLE; CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CODON; CONTROLLED STUDY; ENZYME ACTIVITY; ETHNIC GROUP; EXPOSURE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PHARYNX CANCER; SMOKING; STATISTICAL ANALYSIS; TOBACCO;

EID: 0035211919     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/13547500110057399     Document Type: Article

References (18)

1. CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population
2. The Analysis of Case-Control Studies. Statistical Methods in Cancer Research
3. 609C→T polymorphism with decreased lung cancer risk
4. NAD(P)H:quinone oxidoreductase polymorphisms and allele frequencies in Caucasian, Chinese and Canadian native Indian and Inuit populations
5. NAD(P)H:quinone oxidoreductase 1 (DT-diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase
6. Effects of glutathione S-transferase GSTM1 and GSTT1 genotypes on lung cancer risk among smokers
7. Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers
8. Ethnic variation in the prevalence of a common NAD(P)H:quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy
9. NAD(P)H:quinone oxidoreductase polymorphism and lung cancer in Taiwan
10. A comparative study of smoking, drinking, and dietary habits in population samples in France, Italy, Spain, and Switzerland. III. Consumption of alcohol
11. Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking
12. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1
13. Chemoprotection against cancer by phase 2 enzyme induction
14. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: Characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity
15. Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT-diaphorase)
16. Overall evaluation and research perspectives
17. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H:quinone oxidoreductase polymorphism
18. Enzyme-directed bioreductive drug development revisited: A commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase